DENVER, May 04, 2022--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE:PLTR), a leading builder of operating systems in use across the U.S. government, today announced it had been selected by the Department of Health and Human Services (HHS) for its 5-year "Solutioning with Holistic Analytics Restructured for the Enterprise (SHARE)" Blanket Purchase Agreement (BPA).
This $90 million BPA will allow HHS officials across the department’s many agencies and missions to select the Palantir platform to support their work. Palantir’s built-in data protection features, innovative technology, and common security framework were deemed well positioned to address critical technology needs across HHS.
HHS established the SHARE BPA to provide the best value to the department and its partnering agencies through a pool of prequalified contractors to, among other things, improve the delivery success and quality of data driven insights and outcomes. This contracting vehicle marks the expansion of Palantir’s scope of work at HHS and is separate and distinct from Palantir’s work with HHS and its agencies on COVID-19-related health missions.
Palantir’s first task order obtained under the contract vehicle’s framework is a 10.5-month, multi-million dollar contract to support HHS’s core administrative data and applications through a vertically integrated platform that allows teams to configure low to no code applications to manage, ingest, and access data securely, across business domains.
"We are grateful for our continued partnership with HHS and the confidence in our software it is showing by selecting Palantir for a long-term, wide-ranging BPA," said Akash Jain, president of Palantir USG. "We are proud to provide the software backbone to some of the country’s most critical public health missions."
Palantir Foundry enables data-driven decision-making by integrating data from siloed data sources and enabling granular access to data across various organizations. It is already used by the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration, and was also used by several military branches to mitigate the impact of the COVID-19 pandemic.
About Palantir Technologies Inc.
Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005450/en/